K. Mcgee

SARS-CoV-2-specific nasal IgA wanes 9 months after hospitalisation with COVID-19 and is not induced by subsequent vaccination

Panteleimon G. Takis, Jordan J. Clark, Michael J. Murphy, 2022, eBioMedicine.

Incidence of immune-mediated inflammatory diseases following COVID-19: a matched cohort study in UK primary care

D. Wraith, S. Haroon, K. Nirantharakumar, 2023, BMC Medicine.

Accelerated immune ageing is associated with COVID-19 disease severity

M. G. Jones, M. Halling-Brown, K. Motohashi, 2024, Immunity & Ageing.